CENTRAL PRECOCIOUS PUBERTY MARKET ANALYSIS

Central Precocious Puberty Market, by Drug (Leuprolide Acetate, Triptorelin, Histrelin Acetate, and Nafarelin), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Mar 2022
Code : CMI4960
Pages :167
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Central Precocious Puberty Market – Competitive Landscape

Major players operating in the global central precocious puberty market include Teva Pharmaceutical Industries Ltd., AbbVie Inc., Arbor Pharmaceuticals, LLC, Pfizer Inc., Tolmar Pharmaceuticals, Inc., Endo International plc, Ipsen Pharma, Debiopharm Group, and Sun Pharmaceutical Industries Limited.